1don MSN
With a state grand jury report released Wednesday, Florida Gov. Ron DeSantis doubled down on the message he delivered often ...
The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.
With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...
Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.
A statewide grand jury didn’t find evidence that COVID-19 vaccine manufacturers broke federal or state laws when making and ...
Stocks that have sky-high valuation metrics continue to soar. Value stocks have lagged well behind growth stocks in recent years. Stock valuations still matter, though. Sooner or later, stocks with ...
Moderna is a contrarian play for 2025, despite a rough 2024 as one of the worst-performing Nasdaq-100 stocks. Click here to ...
A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback